A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to evaluate the efficacy of Vortioxetine in an adult
population with a diagnosis of PD. PD is generally treated with benzodiazepines which are
very effective but have a high risk for addiction, fall, and cognitive impairment. There is
still a need for better treatment for PD for longer term use. There are other drugs within
the SSRI/SNRI class which have proven to be effective in treating patients with this
diagnosis.